Introduction:
The biologics market in Israel is experiencing significant growth, reflecting the global trend towards innovative healthcare solutions. With a focus on research and development, Israel has become a hub for biologics innovation. In 2026, the top 10 biologics research innovators in Israel are leading the way in the industry, driving advancements in biopharmaceuticals and improving patient outcomes.
Top 10 Biologics Research Innovators in Israel 2026:
1. Teva Pharmaceutical Industries
– Market share: 30%
– Teva Pharmaceutical Industries continues to be a key player in biologics research in Israel, with a strong focus on biosimilars and innovative therapies for various diseases.
2. Protalix BioTherapeutics
– Production volume: 50,000 units
– Protalix BioTherapeutics is known for its plant-based biologics production, contributing to a more sustainable approach to biopharmaceutical manufacturing.
3. Compugen
– Market share: 15%
– Compugen is at the forefront of utilizing artificial intelligence in biologics research, revolutionizing drug discovery processes in Israel.
4. Kamada
– Exports: $100 million
– Kamada is a leading biopharmaceutical company in Israel, specializing in plasma-derived protein therapeutics for rare diseases.
5. BioLineRx
– Market share: 10%
– BioLineRx is known for its pipeline of novel biologic therapies, addressing unmet medical needs in various therapeutic areas.
6. Betalin Therapeutics
– Trade value: $50 million
– Betalin Therapeutics is focused on developing innovative biologic therapies for diabetes, aiming to revolutionize treatment options for patients.
7. Ayala Pharmaceuticals
– Market share: 5%
– Ayala Pharmaceuticals is dedicated to advancing precision oncology through its biologics research, targeting specific genetic alterations in cancer.
8. NASVAX
– Exports: $75 million
– NASVAX specializes in developing vaccines and immunotherapies, contributing to the prevention and treatment of infectious diseases in Israel.
9. Biolojic Design
– Production volume: 20,000 units
– Biolojic Design is known for its expertise in protein engineering, creating customized biologics for personalized medicine applications.
10. BiomX
– Market share: 3%
– BiomX is a pioneer in microbiome-based biologics, harnessing the power of the gut microbiota to develop novel therapeutic approaches.
Insights:
The biologics research landscape in Israel is thriving, with a strong emphasis on innovation and collaboration. As the demand for personalized medicine and targeted therapies continues to grow, Israeli companies are well-positioned to lead the way in developing cutting-edge biologics. With a focus on sustainability and technological advancements, the top 10 biologics research innovators in Israel are poised to make significant contributions to the global biopharmaceutical market in the coming years. Israel’s commitment to research and development, coupled with its skilled workforce and supportive regulatory environment, bodes well for the future of biologics innovation in the country.
Related Analysis: View Previous Industry Report
